Bacterial Pneumonia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia
Conditions: Community-acquired Pneumonia; Bacterial Pneumonia Interventions: Drug: Omadacycline; Drug: Moxifloxacin Sponsor: Paratek Pharmaceuticals Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2021 Category: Research Source Type: clinical trials

The effect of surfactant on clinical outcome of patients with COVID-19 under mechanical ventilation: A structured summary of a study protocol for a randomised controlled trial
AbstractObjectivesAssessing the effect of surfactant on clinical outcome in patients with COVID-19 under mechanical ventilationTrial designSingle centre, two arm, parallel group (1:1 allocation ratio), randomised superiority trial with blinded care and outcome assessment.ParticipantsInclusion criteria: Adult COVID-19 patients admitted to the ICU in Modarres hospital, Tehran, Iran (age range of 18 to 99 years) with moderate to severe ARDS (based on definition of P/F ratio) requiring auxiliary respiratory devices (either intubation or face mask).Exclusion criteria:● Existence of a major underlying pulmonary disease in addi...
Source: Trials - November 11, 2020 Category: Research Source Type: clinical trials

Phase 1 Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Pneumonia Intervention: Drug: Omadacycline Sponsor: Paratek Pharmaceuticals Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Pneumonia Intervention: Drug: Omadacycline Sponsor: Paratek Pharmaceuticals Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2019 Category: Research Source Type: clinical trials